Skip to main content
Clinical Trials/ISRCTN18100253
ISRCTN18100253Active, not recruiting未知

Effect of maritime pine bark extract (Pycnogenol®) on CoQ10 levels and wellbeing in patients treated with statins

Horphag Research (Switzerland)0 sites60 target enrollmentStarted: March 10, 2023Last updated:

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients with different diagnoses (e.g. CVD, hypertension) who will be treated with any type of statin for the first time and in a dose that will be determined individually based on the established overall CV risk with the aim of achieving target lipid values

Exclusion Criteria

  • 1. Aged < 19 and > 60 years old
  • 2. Acute myocardial infarction (IM) or less than 3 months after IM
  • 3. Active oncological disease
  • 4. Hypothyroidism
  • 5. Diabetes Mellitus
  • 6. Chronic inflammatory disease (e.g. rheumatoid arthritis)
  • 7. Unable/unwilling to sign an informed consent
  • 8. Unable/unwilling to provide samples of biological material as needed

Investigators

Sponsor
Horphag Research (Switzerland)

Similar Trials